AAA November 2011 – Page 3

Pfizer’s interest in Excaliard beyond skin deep

Pharmaceutical conglomerate Pfizer acquired US-based biopharmaceutical company Excaliard yesterday for an undisclosed amount yesterday in a transaction expected to close before the end of the year. Excaliard’s only significant financing since its 2006 founding was a $15.5m series A round in November 2007,  by biomedical company Isis Pharmaceuticals and venture capital firms Alta Partners, ProQuest… Continue reading Pfizer’s interest in Excaliard beyond skin deep

Virgin and Strauss water the investment soil

UK-based conglomerate the Virgin Group and Strauss Water, the drinking water purification and filtration division of Israel-based food and beverage company the Strauss Group, embarked on a joint venture to provide customers with purified drinking water, on Sunday. The Virgin Green Fund, an independent private equity firm affiliated with the Virgin Group, will contribute $7.5m… Continue reading Virgin and Strauss water the investment soil

GE and Neste Jacobs blood strategic partnership

Neste Jacobs, the engineering partnership made up of Norway-based Neste Oil and US-based Jacobs Engineering, and GE Healthcare, the medical technology division of energy conglomerate General Electric, signed a strategic alliance on Monday to assist countries in the manufacturing of blood plasma products by providing an approach to building plants to separate and study blood… Continue reading GE and Neste Jacobs blood strategic partnership

RWE and CEE join forces

RWE Innogy, the renewable energy division of Germany-based energy company the RWE Group, and Conetwork Erneuerbare Energien (CEE), the equity investment division of private bank Banke Lamphaus, sealed a venture capital collaboration agreement on Monday. As part of the deal, CEE has paid €25m ($33.8m) for a 22% stake in the Innogy Renewables Technology Fund… Continue reading RWE and CEE join forces

Mitsui, CEVA see promise with eyeSight

Israel-based touch free electronics interface company eyeSight Mobile Technologies closed a $4.2m series B funding round yesterday, co-led by microprocessor manufacturer CEVA and Mitsui & Co. Global Investment, a corporate venturing unit belonging to Japan-based conglomerate Mitsui. In addition to obtaining equity from the investors, eyeSight will use CEVA’s position to further eyeSight’s reach in… Continue reading Mitsui, CEVA see promise with eyeSight